Enact Holdings, Inc. (ACT) stock
ACTNasdaqInsurance Agents, Brokers & ServiceFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3054% below fair value
$46.16−0.04 (-0.09%)
Close on Nov 11, 2026Market cap $6.35BP/E 9.6Yield 1.77%
Enact EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Enact's EPS for the twelve months ending Sep 30, 2026 was $4.80, up 10.6% year over year. For fiscal 2025 it was $4.52, up 3.4% from the year before. The highest annual figure on record is $4.52 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.52 | +3.4% |
| FY2024 | Dec 31, 2024 | $4.37 | +6.3% |
| FY2023 | Dec 31, 2023 | $4.11 | -4.6% |
| FY2022 | Dec 31, 2022 | $4.31 | +28.3% |
| FY2021 | Dec 31, 2021 | $3.36 | +48.0% |
| FY2020 | Dec 31, 2020 | $2.27 | -45.4% |
| FY2019 | Dec 31, 2019 | $4.16 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.15 | +4.5% |
| Q2 FY2026 | Jun 30, 2026 | $1.25 | +12.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.18 | +9.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.22 | +16.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.10 | -4.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.11 | -4.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.08 | +6.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.05 | +7.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.15 | +12.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.16 | +11.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.01 | -6.5% |
| Q4 FY2023 | Dec 31, 2023 | $0.98 | +11.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.02 | -12.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.04 | -16.8% |
| Q1 FY2023 | Mar 31, 2023 | $1.08 | +6.9% |
| Q4 FY2022 | Dec 31, 2022 | $0.88 | -6.4% |
| Q3 FY2022 | Sep 30, 2022 | $1.17 | +39.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.25 | +56.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.01 | +31.2% |
| Q4 FY2021 | Dec 31, 2021 | $0.94 | +67.9% |
| Q3 FY2021 | Sep 30, 2021 | $0.84 | -1.2% |
| Q2 FY2021 | Jun 30, 2021 | $0.80 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.77 | – |
| Q4 FY2020 | Dec 31, 2020 | $0.56 | – |
| Q3 FY2020 | Sep 30, 2020 | $0.85 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?